Study of sitagliptin/metformin fixed-dose combination (FDC) tablet in healthy Chinese adult subjects

Trial Profile

Study of sitagliptin/metformin fixed-dose combination (FDC) tablet in healthy Chinese adult subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Jul 2016

At a glance

  • Drugs Metformin/sitagliptin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacokinetics
  • Sponsors Merck & Co
  • Most Recent Events

    • 27 Jul 2016 New trial record
    • 08 Jul 2016 Results published in the International Journal of Clinical Pharmacology and Therapeutics
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top